{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:03:02Z","timestamp":1780027382509,"version":"3.53.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007118","name":"Rikkyo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007118","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00846-x","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:24:43Z","timestamp":1780025083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Residue\u2011resolved dynamically averaged interaction analysis of direct factor Xa inhibitors by MD\u2011FMO combination calculations"],"prefix":"10.1007","volume":"40","author":[{"given":"Ryohei","family":"Yoshine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-7991","authenticated-orcid":false,"given":"Yoshinori","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9885-1967","authenticated-orcid":false,"given":"Hideo","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Akisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-5717","authenticated-orcid":false,"given":"Koji","family":"Okuwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8813-5297","authenticated-orcid":false,"given":"Eiji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4579-0195","authenticated-orcid":false,"given":"Kenji","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7310-5183","authenticated-orcid":false,"given":"Yuji","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"2","key":"846_CR1","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.crvasa.2013.02.002","volume":"55","author":"P Widimsk\u00fd","year":"2013","unstructured":"Widimsk\u00fd P, Ko\u017enar B, Va\u0161ko P, Peisker T, \u0160t\u011btk\u00e1\u0159ov\u00e1 I (2013) Acute myocardial infarction and acute stroke: what are the differences? Focus on reperfusion therapy. Cor Vasa 55(2):e111\u2013e116. https:\/\/doi.org\/10.1016\/j.crvasa.2013.02.002","journal-title":"Cor Vasa"},{"issue":"30","key":"846_CR2","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1093\/eurheartj\/ehae371","volume":"45","author":"L Scheldeman","year":"2024","unstructured":"Scheldeman L, Sinnaeve P, Albers GW, Lemmens R, Van de Werf F (2024) Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies\u2014a review. Eur Heart J 45(30):2735\u20132747. https:\/\/doi.org\/10.1093\/eurheartj\/ehae371","journal-title":"Eur Heart J"},{"issue":"5","key":"846_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/ATVBAHA.124.320151","volume":"44","author":"A Wendelboe","year":"2024","unstructured":"Wendelboe A, Weitz JI (2024) Global health burden of venous thromboembolism. Arterioscler Thromb Vasc Biol 44(5):1007\u20131011. https:\/\/doi.org\/10.1161\/ATVBAHA.124.320151","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"43","key":"846_CR4","doi-asserted-by":"publisher","first-page":"10363","DOI":"10.1021\/bi00107a001","volume":"30","author":"EW Davie","year":"1991","unstructured":"Davie EW, Fujikawa K, Kisiel W (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30(43):10363\u201310370. https:\/\/doi.org\/10.1021\/bi00107a001","journal-title":"Biochemistry"},{"issue":"17","key":"846_CR5","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1021\/jm100146h","volume":"53","author":"DJP Pinto","year":"2010","unstructured":"Pinto DJP, Smallheer JM, Cheney DL, Knabb RM, Wexler RR (2010) Factor Xa inhibitors: next-generation antithrombotic agents. J Med Chem 53(17):6243\u20136274. https:\/\/doi.org\/10.1021\/jm100146h","journal-title":"J Med Chem"},{"issue":"6","key":"846_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.thromres.2010.09.008","volume":"127","author":"MM Samama","year":"2011","unstructured":"Samama MM (2011) The mechanism of action of rivaroxaban\u2014an oral, direct factor Xa inhibitor\u2014compared with other anticoagulants. Thromb Res 127(6):497\u2013504. https:\/\/doi.org\/10.1016\/j.thromres.2010.09.008","journal-title":"Thromb Res"},{"issue":"2","key":"846_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1570163811209020083","volume":"9","author":"A G\u00f3mez-Outes","year":"2012","unstructured":"G\u00f3mez-Outes A, Su\u00e1rez-Gea ML, Calvo-Rojas G, Lecumberri R, Rocha E, Pozo-Hern\u00e1ndez C, Terleira-Fern\u00e1ndez AI, Vargas-Castrill\u00f3n E (2012) Discovery of anticoagulant drugs: a historical perspective. Curr Drug Discov Technol 9(2):83\u2013104. https:\/\/doi.org\/10.2174\/1570163811209020083","journal-title":"Curr Drug Discov Technol"},{"issue":"8","key":"846_CR8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/CIRCRESAHA.112.276741","volume":"111","author":"CH Yeh","year":"2012","unstructured":"Yeh CH, Fredenburgh JC, Weitz JI (2012) Oral direct factor Xa inhibitors. Circ Res 111(8):1069\u20131078. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.276741","journal-title":"Circ Res"},{"key":"846_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/TCRM.S84210","volume":"11","author":"MH Mekaj","year":"2015","unstructured":"Mekaj MH, Mekaj AY, Duci SB, Miftari EI (2015) New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag 11:967\u2013977. https:\/\/doi.org\/10.2147\/TCRM.S84210","journal-title":"Ther Clin Risk Manag"},{"issue":"12","key":"846_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3949\/ccjm.82a.14052","volume":"82","author":"B Roca","year":"2015","unstructured":"Roca B, Roca M (2015) The new oral anticoagulants: reasonable alternatives to warfarin. Cleve Clin J Med 82(12):847\u2013854. https:\/\/doi.org\/10.3949\/ccjm.82a.14052","journal-title":"Cleve Clin J Med"},{"key":"846_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ejmech.2016.05.039","volume":"121","author":"NR Patel","year":"2016","unstructured":"Patel NR, Patel DV, Murumkar PR, Yadav MR (2016) Contemporary developments in the discovery of selective factor Xa inhibitors: a review. Eur J Med Chem 121:671\u2013698. https:\/\/doi.org\/10.1016\/j.ejmech.2016.05.039","journal-title":"Eur J Med Chem"},{"key":"846_CR12","doi-asserted-by":"publisher","unstructured":"Zacconi FC (2018) FXa direct synthetic inhibitors. In: Bo\u017ei\u010d-Mijovski M (ed) Anticoagulant drugs. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.76518","DOI":"10.5772\/intechopen.76518"},{"key":"846_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1105880","volume":"14","author":"W Zheng","year":"2023","unstructured":"Zheng W, Dai X, Xu B, Tian W, Shi J (2023) Discovery and development of factor Xa inhibitors (2015\u20132022). Front Pharmacol 14:1105880. https:\/\/doi.org\/10.3389\/fphar.2023.1105880","journal-title":"Front Pharmacol"},{"key":"846_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tru.2024.100185","volume":"16","author":"C Jones","year":"2024","unstructured":"Jones C, Idowu A, Obomanu E, Smith R, Byfield K, Ramkissoon A, Lo KB, Mayo R (2024) Management of heparin-induced thrombocytopenia with factor Xa inhibitors: a systematic review. Thromb Update 16:100185. https:\/\/doi.org\/10.1016\/j.tru.2024.100185","journal-title":"Thromb Update"},{"issue":"3","key":"846_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5551\/jat.64223","volume":"31","author":"K Toyoda","year":"2024","unstructured":"Toyoda K, Arakawa S, Ezura M, Kobayashi R, Tanaka Y, Hasegawa S, Yamashiro S, Komatsu Y, Terasawa Y, Masuno T, Kobayashi H, Oikawa S, Yasaka M (2024) Andexanet Alfa for the reversal of factor Xa inhibitor activity: prespecified subgroup analysis of the ANNEXA-4 study in Japan. J Atheroscler Thromb 31(3):201\u2013213. https:\/\/doi.org\/10.5551\/jat.64223","journal-title":"J Atheroscler Thromb"},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s12028-024-02130-y","volume":"42","author":"K Sarhan","year":"2025","unstructured":"Sarhan K, Mohamed RG, Elmahdi RR, Mohsen Y, Elsayed A, Zayed DM, Elkholi MA, Gabr N, El-Bialy EM, Serag I (2025) Efficacy and safety of Andexanet Alfa versus four-factor prothrombin complex concentrate for emergent reversal of factor Xa inhibitor associated intracranial hemorrhage: a systematic review and meta-analysis. Neurocrit Care 42:701\u2013714. https:\/\/doi.org\/10.1007\/s12028-024-02130-y","journal-title":"Neurocrit Care"},{"key":"846_CR17","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/imj.70103","volume":"55","author":"HA Tran","year":"2025","unstructured":"Tran HA, Merriman E, Baker R, Curnow J, Young L, Tan CW, McRae S, Chunilal SD (2025) 2025 guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri-operative and bleeding management. Intern Med J 55:1174\u20131183. https:\/\/doi.org\/10.1111\/imj.70103","journal-title":"Intern Med J"},{"key":"846_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40256-020-00438-6","volume":"20","author":"RA Al-Horani","year":"2020","unstructured":"Al-Horani RA (2020) Potential therapeutic roles for direct factor Xa inhibitors in coronavirus infections. Am J Cardiovasc Drugs 20:525\u2013533. https:\/\/doi.org\/10.1007\/s40256-020-00438-6","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1","key":"846_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262482","volume":"17","author":"K Papaj","year":"2022","unstructured":"Papaj K, Spychalska P, Kapica P, Fischer A, Nowak J, Bz\u00f3wka M, Sellner M, Lill MA, Smie\u0161ko M, G\u00f3ra A (2022) Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease. PLoS ONE 17(1):e0262482. https:\/\/doi.org\/10.1371\/journal.pone.0262482","journal-title":"PLoS ONE"},{"issue":"1159","key":"846_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/postgradmedj-2021-139923","volume":"98","author":"A Chandra","year":"2022","unstructured":"Chandra A, Chakraborty U, Ghosh S, Dasgupta S (2022) Anticoagulation in COVID-19: current concepts and controversies. Postgrad Med J 98(1159):395\u2013402. https:\/\/doi.org\/10.1136\/postgradmedj-2021-139923","journal-title":"Postgrad Med J"},{"issue":"7","key":"846_CR21","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1097\/MS9.0000000000002079","volume":"86","author":"L Amin","year":"2024","unstructured":"Amin L, Qayyum K, Uzair M, Khan F, Sethi P, Hanif L, Azhar A, Mazhar S, Ejaz U, Jawad S (2024) Factor Xa inhibitors versus low-molecular-weight heparin for preventing coagulopathy following COVID-19: a systematic review and meta-analysis of randomized controlled trials. Ann Med Surg (Lond) 86(7):4075\u20134082. https:\/\/doi.org\/10.1097\/MS9.0000000000002079","journal-title":"Ann Med Surg (Lond)"},{"issue":"9","key":"846_CR22","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1111\/j.1538-7836.2008.03064.x","volume":"6","author":"T Furugohri","year":"2008","unstructured":"Furugohri T, Isobe K, Honda Y, Kamisato-Matsumoto C, Sugiyama N, Nagahara T, Morishima Y, Shibano T (2008) DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. J Thromb Haemost 6(9):1542\u20131549. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03064.x","journal-title":"J Thromb Haemost"},{"issue":"8","key":"846_CR23","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.bmcl.2009.02.111","volume":"19","author":"P Zhang","year":"2009","unstructured":"Zhang P, Huang W, Wang L, Bao LJ, Jia ZJ, Bauer SM, Goldman EA, Probst GD, Song Y, Su T, Fan J, Wu Y, Li W, Woolfrey J, Sinha U, Wong PW, Edwards ST, Arfsten AE, Clizbe LA, Kanter J, Pandey A, Park G, Hutchaleelaha A, Lambing JL, Hollenbach SJ, Scarborough RM, Zhu B-Y (2009) Discovery of betrixaban (PRT054021). Bioorg Med Chem Lett 19(8):2179\u20132185. https:\/\/doi.org\/10.1016\/j.bmcl.2009.02.111","journal-title":"Bioorg Med Chem Lett"},{"issue":"22","key":"846_CR24","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1021\/jm070245n","volume":"50","author":"DJP Pinto","year":"2007","unstructured":"Pinto DJP, Orwat MJ, Koch S, Rossi KA, Alexander RS, Smallwood A, Wong PC, Rendina AR, Luettgen JM, Knabb RM, He K, Xin B, Wexler RR, Lam PYS (2007) Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo3,4\u2013c3,4\u2212cpyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa. J Med Chem 50(22):5339\u20135356. https:\/\/doi.org\/10.1021\/jm070245n","journal-title":"J Med Chem"},{"issue":"4","key":"846_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fphar.2013.00145","volume":"25","author":"D Kubitza","year":"2013","unstructured":"Kubitza D, Perzborn E, Berkowitz SD (2013) The discovery of rivaroxaban: translating preclinical assessments into clinical practice. Front Pharmacol 25(4):145. https:\/\/doi.org\/10.3389\/fphar.2013.00145","journal-title":"Front Pharmacol"},{"issue":"3","key":"846_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5923\/j.bioinformatics.20120203.01","volume":"2","author":"SB Vepuri","year":"2012","unstructured":"Vepuri SB, Anbazhagan S, N P, Divya D (2012) Pharmacophore modeling and docking based QSAR studies of aryl amidino isoxazoline derivatives to design potential FXa inhibitors. Am J Bioinform Res 2(3):11\u201320. https:\/\/doi.org\/10.5923\/j.bioinformatics.20120203.01","journal-title":"Am J Bioinform Res"},{"issue":"6","key":"846_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/08927022.2012.741235","volume":"39","author":"JB Ghasemi","year":"2013","unstructured":"Ghasemi JB, Hooshmand S (2013) 3D-QSAR, docking and molecular dynamics for factor Xa inhibitors as anticoagulant agents. Mol Simul 39(6):453\u2013471. https:\/\/doi.org\/10.1080\/08927022.2012.741235","journal-title":"Mol Simul"},{"key":"846_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/120802","volume":"2015","author":"VB Sulimov","year":"2015","unstructured":"Sulimov VB, Gribkova IV, Kochugaeva MP, Katkova EV, Sulimov AV, Kutov DC, Shikhaliev KS, Medvedeva SM, Krysin MY, Sinauridze EI, Ataullakhanov FI (2015) Application of molecular modeling to development of new factor Xa inhibitors. BioMed Res Int 2015:120802. https:\/\/doi.org\/10.1155\/2015\/120802","journal-title":"BioMed Res Int"},{"key":"846_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109086","volume":"166","author":"F Meletli","year":"2025","unstructured":"Meletli F, Ogan A, Yanardag R, Sacan O (2025) Effects of some 7-hydroxy coumarin compounds on coagulation factor Xa, urease and antidiabetic enzymes. Bioorg Chem 166:109086. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109086","journal-title":"Bioorg Chem"},{"issue":"13","key":"846_CR30","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.3390\/molecules28134977","volume":"28","author":"M Gackowski","year":"2023","unstructured":"Gackowski M, Madriwala B, Studzi\u0144ska R, Koba M (2023) Novel isosteviol-based FXa inhibitors: molecular modeling, in silico design and docking simulation. Molecules 28(13):4977. https:\/\/doi.org\/10.3390\/molecules28134977","journal-title":"Molecules"},{"issue":"2","key":"846_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/(SICI)1097-0134(19990201)34:2<173::AID-PROT3>3.0.CO;2-F","volume":"34","author":"MS Rao","year":"1999","unstructured":"Rao MS, Olson AJ (1999) Modelling of factor Xa\u2013inhibitor complexes: a computational flexible docking approach. Proteins 34(2):173\u2013183. https:\/\/doi.org\/10.1002\/(SICI)1097-0134(19990201)34:2%3c173::AID-PROT3%3e3.0.CO;2-F","journal-title":"Proteins"},{"issue":"26","key":"846_CR32","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1021\/jm030288d","volume":"46","author":"D Ostrovsky","year":"2003","unstructured":"Ostrovsky D, Udier-Blagovi\u0107 M, Jorgensen WL (2003) Analyses of activity for factor Xa inhibitors based on Monte Carlo simulations. J Med Chem 46(26):5691\u20135699. https:\/\/doi.org\/10.1021\/jm030288d","journal-title":"J Med Chem"},{"issue":"3","key":"846_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1021\/jm0202324","volume":"46","author":"LM McDowell","year":"2003","unstructured":"McDowell LM, McCarrick MA, Studelska DR, O\u2019Connor RD, Light DR, Guilford WJ, Arnaiz D, Adler M, Dallas JL, Poliks B, Schaefer J (2003) Human factor Xa\u2013bound amidine inhibitor conformation by double rotational-echo double-resonance nuclear magnetic resonance and molecular dynamics simulations. J Med Chem 46(3):359\u2013363. https:\/\/doi.org\/10.1021\/jm0202324","journal-title":"J Med Chem"},{"issue":"9","key":"846_CR34","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1021\/ja0771033","volume":"130","author":"R Abel","year":"2008","unstructured":"Abel R, Young T, Farid R, Berne BJ, Friesner RA (2008) Role of the active-site solvent in the thermodynamics of factor Xa ligand binding. J Am Chem Soc 130(9):2817\u20132831. https:\/\/doi.org\/10.1021\/ja0771033","journal-title":"J Am Chem Soc"},{"issue":"8","key":"846_CR35","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1021\/ci200185q","volume":"51","author":"SS Bhunia","year":"2011","unstructured":"Bhunia SS, Roy KK, Saxena AK (2011) Profiling the structural determinants for the selectivity of representative factor Xa and thrombin inhibitors using combined ligand-based and structure-based approaches. J Chem Inf Model 51(8):1966\u20131985. https:\/\/doi.org\/10.1021\/ci200185q","journal-title":"J Chem Inf Model"},{"issue":"4","key":"846_CR36","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1021\/ci100458f","volume":"51","author":"S Genheden","year":"2011","unstructured":"Genheden S, Nilsson I, Ryde U (2011) Binding affinities of factor Xa inhibitors estimated by thermodynamic integration and MM\/GBSA. J Chem Inf Model 51(4):947\u2013958. https:\/\/doi.org\/10.1021\/ci100458f","journal-title":"J Chem Inf Model"},{"issue":"2","key":"846_CR37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/07391102.2019.1583605","volume":"38","author":"Q Du","year":"2020","unstructured":"Du Q, Qian Y, Yao X, Xue W (2020) Elucidating the tight-binding mechanism of two oral anticoagulants to factor Xa by using induced-fit docking and molecular dynamics simulation. J Biomol Struct Dyn 38(2):625\u2013633. https:\/\/doi.org\/10.1080\/07391102.2019.1583605","journal-title":"J Biomol Struct Dyn"},{"issue":"19","key":"846_CR38","doi-asserted-by":"publisher","first-page":"13013","DOI":"10.1021\/acs.jmedchem.2c00865","volume":"65","author":"MI Fern\u00e1ndez-Bachiller","year":"2022","unstructured":"Fern\u00e1ndez-Bachiller MI, Hwang S, Schembri ME, Lindemann P, Guberman M, Herziger S, Specker E, Matter H, Will DW, Czech J, Wagner M, Bauer A, Schreuder H, Ritter K, Urmann M, Wehner V, Sun H, Nazar\u00e9 M (2022) Probing factor Xa protein\u2013ligand interactions: accurate free energy calculations and experimental validations of two series of high-affinity ligands. J Med Chem 65(19):13013\u201313028. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00865","journal-title":"J Med Chem"},{"key":"846_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.877170","volume":"9","author":"X Zhang","year":"2022","unstructured":"Zhang X, Chen C, Qu S-Y, Ding Q (2022) Unexpected dynamic binding may rescue the binding affinity of rivaroxaban in a mutant of coagulation factor X. Front Mol Biosci 9:877170. https:\/\/doi.org\/10.3389\/fmolb.2022.877170","journal-title":"Front Mol Biosci"},{"issue":"9","key":"846_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28093851","volume":"28","author":"NP Novichikhina","year":"2023","unstructured":"Novichikhina NP, Shestakov AS, Medvedeva SM, Lagutina AM, Krysin MY, Podoplelova NA, Panteleev MA, Ilin IS, Sulimov AV, Tashchilova AS, Sulimov VB, Geronikaki A, Shikhaliev KS (2023) New hybrid tetrahydropyrrolo3,2,1\u2212ij3,2,1\u2212ijquinolin-1-ylidene-2-thioxothiazolidin-4-ones as new inhibitors of factor Xa and factor XIa: design, synthesis, and in silico and experimental evaluation. Molecules 28(9):3851. https:\/\/doi.org\/10.3390\/molecules28093851","journal-title":"Molecules"},{"key":"846_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.comptc.2023.114131","volume":"1225","author":"Q Li","year":"2023","unstructured":"Li Q, Zhang H, Guan S, Du J, Zhang Y, Wang S (2023) Molecular dynamics simulation of the inhibition mechanism of factor XIa by milvexian-like macrocyclic inhibitors. Comput Theor Chem 1225:114131. https:\/\/doi.org\/10.1016\/j.comptc.2023.114131","journal-title":"Comput Theor Chem"},{"issue":"10","key":"846_CR42","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1080\/07391102.2022.2072387","volume":"41","author":"DA Shulga","year":"2023","unstructured":"Shulga DA, Tserkovnikova NA, Tarasov DN, Tovbin DG (2023) Investigation of the tight binding mechanism of a new anticoagulant DD217 to factor Xa by means of molecular docking and molecular dynamics. J Biomol Struct Dyn 41(10):4723\u20134734. https:\/\/doi.org\/10.1080\/07391102.2022.2072387","journal-title":"J Biomol Struct Dyn"},{"issue":"21","key":"846_CR43","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1021\/jm049884d","volume":"47","author":"N Haginoya","year":"2004","unstructured":"Haginoya N, Kobayashi S, Komoriya S, Yoshino T, Suzuki M, Shimada T, Watanabe K, Hirokawa Y, Furugori T, Nagahara T (2004) Synthesis and conformational analysis of a non-amidine factor Xa inhibitor that incorporates 5-methyl-4,5,6,7-tetrahydrothiazolo5,4\u2013c5,4\u2212cpyridine as S4 binding element. J Med Chem 47(21):5167\u20135182. https:\/\/doi.org\/10.1021\/jm049884d","journal-title":"J Med Chem"},{"issue":"2","key":"846_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/molecules21020185","volume":"21","author":"M Remko","year":"2016","unstructured":"Remko M, Remkov\u00e1 A, Broer R (2016) Theoretical study of molecular structure and physicochemical properties of novel factor Xa inhibitors and dual factor Xa and factor IIa inhibitors. Molecules 21(2):185. https:\/\/doi.org\/10.3390\/molecules21020185","journal-title":"Molecules"},{"issue":"Part2","key":"846_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.137049","volume":"1298","author":"\u017d Milanovi\u0107","year":"2024","unstructured":"Milanovi\u0107 \u017d (2024) Structural properties of newly 4,7-dihydroxycoumarin derivatives as potential inhibitors of XIIa, Xa, IIa factors of coagulation. J Mol Struct 1298(Part2):137049. https:\/\/doi.org\/10.1016\/j.molstruc.2023.137049","journal-title":"J Mol Struct"},{"issue":"11","key":"846_CR46","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/psp4.12035","volume":"4","author":"X Zhou","year":"2015","unstructured":"Zhou X, Huntjens D, Gilissen R (2015) A systems pharmacology model for predicting effects of factor Xa inhibitors in healthy subjects: assessment of pharmacokinetics and binding kinetics. CPT Pharmacomet Syst Pharmacol 4(11):650\u2013659. https:\/\/doi.org\/10.1002\/psp4.12035","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"3\u20134","key":"846_CR47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0009-2614(99)00874-X","volume":"313","author":"K Kitaura","year":"1999","unstructured":"Kitaura K, Ikeo E, Asada T, Nakano T, Uebayasi M (1999) Fragment molecular orbital method: an approximate computational method for large molecules. Chem Phys Lett 313(3\u20134):701\u2013706. https:\/\/doi.org\/10.1016\/S0009-2614(99)00874-X","journal-title":"Chem Phys Lett"},{"issue":"1","key":"846_CR48","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1021\/cr200093j","volume":"112","author":"MS Gordon","year":"2012","unstructured":"Gordon MS, Fedorov DG, Pruitt SR, Slipchenko LV (2012) Fragmentation methods: a route to accurate calculations on large systems. Chem Rev 112(1):632\u2013672. https:\/\/doi.org\/10.1021\/cr200093j","journal-title":"Chem Rev"},{"issue":"12","key":"846_CR49","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.1021\/cr500455b","volume":"115","author":"MA Collins","year":"2015","unstructured":"Collins MA, Bettens RPA (2015) Energy-based molecular fragmentation methods. Chem Rev 115(12):5607\u20135642. https:\/\/doi.org\/10.1021\/cr500455b","journal-title":"Chem Rev"},{"issue":"12","key":"846_CR50","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1021\/cr500606e","volume":"115","author":"K Raghavachari","year":"2015","unstructured":"Raghavachari K, Saha A (2015) Accurate composite and fragment-based quantum chemical models for large molecules. Chem Rev 115(12):5643\u20135677. https:\/\/doi.org\/10.1021\/cr500606e","journal-title":"Chem Rev"},{"key":"846_CR51","doi-asserted-by":"publisher","DOI":"10.1063\/1.5126216","volume":"151","author":"JM Herbert","year":"2019","unstructured":"Herbert JM (2019) Fantasy versus reality in fragment-based quantum chemistry. J Chem Phys 151:170901. https:\/\/doi.org\/10.1063\/1.5126216","journal-title":"J Chem Phys"},{"key":"846_CR52","doi-asserted-by":"publisher","DOI":"10.1201\/9781420078497","volume-title":"Kitaura K (2009) The fragment molecular orbital method: practical applications to large molecular systems","author":"DG Fedorov","year":"2009","unstructured":"Fedorov DG (2009) Kitaura K (2009) The fragment molecular orbital method: practical applications to large molecular systems. CRC Press, Boca Raton"},{"key":"846_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-9235-5","volume-title":"Fukuzawa K (2021) Recent advances of the fragment molecular orbital method: enhanced performance and applicability","author":"Y Mochizuki","year":"2021","unstructured":"Mochizuki Y, Tanaka S (2021) Fukuzawa K (2021) Recent advances of the fragment molecular orbital method: enhanced performance and applicability. Springer, Singapore"},{"key":"846_CR54","doi-asserted-by":"publisher","first-page":"7562","DOI":"10.1039\/C2CP23784A","volume":"14","author":"DG Fedorov","year":"2012","unstructured":"Fedorov DG, Nagata T, Kitaura K (2012) Exploring chemistry with the fragment molecular orbital method. Phys Chem Chem Phys 14:7562\u20137577. https:\/\/doi.org\/10.1039\/C2CP23784A","journal-title":"Phys Chem Chem Phys"},{"key":"846_CR55","doi-asserted-by":"publisher","first-page":"10310","DOI":"10.1039\/C4CP00316K","volume":"16","author":"S Tanaka","year":"2014","unstructured":"Tanaka S, Mochizuki Y, Komeiji Y, Okiyama Y, Fukuzawa K (2014) Electron-correlated fragment molecular orbital calculations for biomolecular and nano systems. Phys Chem Chem Phys 16:10310\u201310344. https:\/\/doi.org\/10.1039\/C4CP00316K","journal-title":"Phys Chem Chem Phys"},{"issue":"1","key":"846_CR56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1021\/ci050262q","volume":"46","author":"S Amari","year":"2006","unstructured":"Amari S, Aizawa M, Zhang J, Fukuzawa K, Mochizuki Y, Iwasawa Y, Nakata K, Chuman H, Nakano T (2006) VISCANA: visualized cluster analysis of protein\u2013ligand interaction based on the ab initio fragment molecular orbital method for virtual ligand screening. J Chem Inf Model 46(1):221\u2013229. https:\/\/doi.org\/10.1021\/ci050262q","journal-title":"J Chem Inf Model"},{"issue":"1","key":"846_CR57","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/jcc.20496","volume":"28","author":"DG Fedorov","year":"2007","unstructured":"Fedorov DG, Kitaura K (2007) Pair interaction energy decomposition analysis. J Comput Chem 28(1):222\u2013230. https:\/\/doi.org\/10.1002\/jcc.20496","journal-title":"J Comput Chem"},{"issue":"1","key":"846_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2477\/jccj.2014-0039","volume":"14","author":"T Tsukamoto","year":"2015","unstructured":"Tsukamoto T, Kato K, Kato A, Nakano T, Mochizuki Y, Fukuzawa K (2015) Implementation of pair interaction energy decomposition analysis and its applications to protein\u2013ligand systems. J Comput Chem Jpn 14(1):1\u20139. https:\/\/doi.org\/10.2477\/jccj.2014-0039","journal-title":"J Comput Chem Jpn"},{"issue":"12","key":"846_CR59","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/jcc.27297","volume":"45","author":"S Matsuoka","year":"2024","unstructured":"Matsuoka S, Sakakura K, Akinaga Y, Akisawa K, Okuwaki K, Doi H, Mochizuki Y (2024) Enhancement of energy decomposition analysis in fragment molecular orbital calculations. J Comput Chem 45(12):898\u2013902. https:\/\/doi.org\/10.1002\/jcc.27297","journal-title":"J Comput Chem"},{"key":"846_CR60","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1007\/978-1-0716-0282-9","volume-title":"Quantum mechanics in drug discovery","author":"A Heifetz","year":"2020","unstructured":"Heifetz A (2020) Quantum mechanics in drug discovery. Humana Press, New York, p 2020"},{"issue":"10","key":"846_CR61","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1021\/jp075430r","volume":"112","author":"M Ito","year":"2008","unstructured":"Ito M, Fukuzawa K, Mochizuki Y, Nakano T, Tanaka S (2008) Ab initio fragment molecular orbital study of molecular interactions between liganded retinoid X receptor and its coactivator. Part II: influence of mutations in transcriptional activation function 2 activating domain core on the molecular interactions. J Phys Chem A 112(10):1986\u20131998. https:\/\/doi.org\/10.1021\/jp075430r","journal-title":"J Phys Chem A"},{"issue":"16","key":"846_CR62","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1002\/jcc.21265","volume":"30","author":"T Ishikawa","year":"2009","unstructured":"Ishikawa T, Ishikura T, Kuwata K (2009) Theoretical study of the prion protein based on the fragment molecular orbital method. J Comput Chem 30(16):2594\u20132601. https:\/\/doi.org\/10.1002\/jcc.21265","journal-title":"J Comput Chem"},{"key":"846_CR63","doi-asserted-by":"publisher","DOI":"10.35848\/1882-0786\/abdac6","volume":"14","author":"R Hatada","year":"2021","unstructured":"Hatada R, Okuwaki K, Akisawa K, Mochizuki Y, Handa Y, Fukuzawa K, Komeiji Y, Okiyama Y, Tanaka S (2021) Statistical interaction analyses between SARS-CoV-2 main protease and inhibitor N3 by combining molecular dynamics simulation and fragment molecular orbital calculation. Appl Phys Express 14:027003. https:\/\/doi.org\/10.35848\/1882-0786\/abdac6","journal-title":"Appl Phys Express"},{"issue":"24","key":"846_CR64","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1021\/acs.jpcb.1c03043","volume":"125","author":"S Tanaka","year":"2021","unstructured":"Tanaka S, Tokutomi S, Hatada R, Okuwaki K, Akisawa K, Fukuzawa K, Komeiji Y, Okiyama Y, Mochizuki Y (2021) Dynamic cooperativity of ligand\u2013residue interactions evaluated with the fragment molecular orbital method. J Phys Chem B 125(24):6501\u20136512. https:\/\/doi.org\/10.1021\/acs.jpcb.1c03043","journal-title":"J Phys Chem B"},{"issue":"20","key":"846_CR65","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/jcc.26940","volume":"43","author":"K Takaba","year":"2022","unstructured":"Takaba K, Watanabe C, Tokuhisa A, Akinaga Y, Ma B, Kanada R, Araki M, Okuno Y, Kawashima Y, Moriwaki H, Kawashita N, Honma T, Fukuzawa K, Tanaka S (2022) Protein\u2013ligand binding affinity prediction of cyclin-dependent kinase-2 inhibitors by dynamically averaged fragment molecular orbital-based interaction energy. J Comput Chem 43(20):1362\u20131371. https:\/\/doi.org\/10.1002\/jcc.26940","journal-title":"J Comput Chem"},{"issue":"10","key":"846_CR66","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1021\/acs.jpcb.3c05564","volume":"128","author":"Y Handa","year":"2024","unstructured":"Handa Y, Okuwaki K, Kawashima Y, Hatada R, Mochizuki Y, Komeiji Y, Tanaka S, Furuishi T, Yonemochi E, Honma T, Fukuzawa K (2024) Prediction of binding pose and affinity of nelfinavir, a SARS-CoV-2 main protease repositioned drug, by combining docking, molecular dynamics, and fragment molecular orbital calculations. J Phys Chem B 128(10):2249\u20132265. https:\/\/doi.org\/10.1021\/acs.jpcb.3c05564","journal-title":"J Phys Chem B"},{"issue":"2","key":"846_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/chemle\/upaf030","volume":"54","author":"K Akisawa","year":"2025","unstructured":"Akisawa K, Sakuma Y, Tsukamoto A, Doi H, Okuwaki K, Hirano Y, Yamamoto E, Yasuoka K, Mochizuki Y (2025) FMO-based interaction analysis on DEET\/Icaridin\u2013AgamOBP1 complex. Chem Lett 54(2):upaf030. https:\/\/doi.org\/10.1093\/chemle\/upaf030","journal-title":"Chem Lett"},{"issue":"4","key":"846_CR68","doi-asserted-by":"publisher","first-page":"60874","DOI":"10.1021\/acsomega.5c09502","volume":"10","author":"S Miyakawa","year":"2025","unstructured":"Miyakawa S, Okuwaki K, Kawashima Y, Handa Y, Furuishi T, Yonemochi E, Kato K, Fukuzawa K (2025) Dynamical fragment molecular orbital interaction analysis of SARS-CoV-2 RNA-dependent RNA polymerase and remdesivir. ACS Omega 10(4):60874\u201360885. https:\/\/doi.org\/10.1021\/acsomega.5c09502","journal-title":"ACS Omega"},{"issue":"4","key":"846_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.70052","volume":"46","author":"H Doi","year":"2025","unstructured":"Doi H, Nakano T, Sakakura K, Akisawa K, Okuwaki K, Hirano Y, Yamamoto E, Yasuoka K, Ohshima S, Katagiri T, Mochizuki Y (2025) Large-scale FMO-MP2 calculations of the spike protein droplet model. J Comput Chem 46(4):e70052. https:\/\/doi.org\/10.1002\/jcc.70052","journal-title":"J Comput Chem"},{"issue":"11","key":"846_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.70382","volume":"47","author":"Y Enomoto","year":"2026","unstructured":"Enomoto Y, Mori Y, Fukuzawa K, Tanaka S (2026) Statistical protein-protein interaction analysis of HER2-Pertuzumab complex by the fragment molecular orbital method. J Comput Chem 47(11):e70382. https:\/\/doi.org\/10.1002\/jcc.70382","journal-title":"J Comput Chem"},{"key":"846_CR71","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.sbi.2021.08.010","volume":"72","author":"K Fukuzawa","year":"2022","unstructured":"Fukuzawa K, Tanaka S (2022) Fragment molecular orbital calculations for biomolecules. Curr Opin Struct Biol 72:127\u2013134. https:\/\/doi.org\/10.1016\/j.sbi.2021.08.010","journal-title":"Curr Opin Struct Biol"},{"key":"846_CR72","unstructured":"Chemical Computing Group ULC (2013) Molecular operating environment (MOE). 1010 Sherbrooke St. West, Suite 910, Montreal, QC, Canada, H3A 2R7. https:\/\/www.chemcomp.com\/en\/index.htm"},{"issue":"3","key":"846_CR73","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.bmc.2008.12.037","volume":"17","author":"T Nagata","year":"2009","unstructured":"Nagata T, Yoshino T, Haginoya N, Yoshikawa K, Nagamochi M, Kobayashi S, Komoriya S, Yokomizo A, Muto R, Yamaguchi M, Osanai K, Suzuki M, Kanno H (2009) Discovery of N-[(1R,2S,5S)-2-{[(5-chloroindol-2-yl)carbonyl]amino}-5-(dimethylcarbamoyl)cyclohexyl]-5-methyl-4,5,6,7-tetrahydrothiazolo5,4\u2013c5,4\u2212cpyridine-2-carboxamide hydrochloride: a novel, potent and orally active direct inhibitor of factor Xa. Bioorg Med Chem 17(3):1193\u20131206. https:\/\/doi.org\/10.1016\/j.bmc.2008.12.037","journal-title":"Bioorg Med Chem"},{"key":"846_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"issue":"8","key":"846_CR75","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11(8):3696\u20133713. https:\/\/doi.org\/10.1021\/acs.jctc.5b00255","journal-title":"J Chem Theory Comput"},{"key":"846_CR76","doi-asserted-by":"publisher","DOI":"10.1063\/5.0019056","volume":"153","author":"X He","year":"2020","unstructured":"He X, Man VH, Yang W, Lee T-S, Wang J (2020) A fast and high-quality charge model for the next generation general AMBER force field. J Chem Phys 153:114502. https:\/\/doi.org\/10.1063\/5.0019056","journal-title":"J Chem Phys"},{"key":"846_CR77","volume-title":"Modern quantum chemistry","author":"A Szabo","year":"1982","unstructured":"Szabo A, Ostlund NS (1982) Modern quantum chemistry. Macmillan, New York"},{"key":"846_CR78","volume-title":"Exploring chemistry with electronic structure methods","author":"JB Foresman","year":"1996","unstructured":"Foresman JB, Frisch A (1996) Exploring chemistry with electronic structure methods, 2nd edn. Gaussian Inc., Pittsburgh","edition":"2"},{"key":"846_CR79","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1063\/1.1677527","volume":"56","author":"WJ Hehre","year":"1972","unstructured":"Hehre WJ, Ditchfield R, Pople JA (1972) Self-consistent molecular orbital methods. XII. Further extensions of Gaussian-type basis sets for use in molecular orbital studies of organic molecules. J Chem Phys 56:2257\u20132261. https:\/\/doi.org\/10.1063\/1.1677527","journal-title":"J Chem Phys"},{"key":"846_CR80","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF00533485","volume":"28","author":"PC Hariharan","year":"1973","unstructured":"Hariharan PC, Pople JA (1973) The influence of polarization functions on molecular orbital hydrogenation energies. Theor Chim Acta 28:213\u2013222. https:\/\/doi.org\/10.1007\/BF00533485","journal-title":"Theor Chim Acta"},{"key":"846_CR81","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H, Li X, Caricato M, Marenich AV, Bloino J, Janesko BG, Gomperts R, Mennucci B, Hratchian HP, Ortiz JV, Izmaylov AF, Sonnenberg JL, Williams-Young D, Ding F, Lipparini F, Egidi F, Goings J, Peng B, Petrone A, Henderson T, Ranasinghe D, Zakrzewski VG, Gao J, Rega N, Zheng G, Liang W, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Throssell K, Montgomery JA Jr, Peralta JE, Ogliaro F, Bearpark MJ, Heyd JJ, Brothers EN, Kudin KN, Staroverov VN, Keith TA, Kobayashi R, Normand J, Raghavachari K, Rendell AP, Burant JC, Iyengar SS, Tomasi J, Cossi M, Millam JM, Klene M, Adamo C, Cammi R, Ochterski JW, Martin RL, Morokuma K, Farkas O, Foresman JB, Fox DJ (2016) Gaussian 16, revision C.01. Gaussian Inc., Wallingford CT, 2016. https:\/\/gaussian.com\/"},{"issue":"21","key":"846_CR82","doi-asserted-by":"publisher","first-page":"9620","DOI":"10.1021\/ja00074a030","volume":"115","author":"WD Cornell","year":"1993","unstructured":"Cornell WD, Cieplak P, Bayly CB, Kollman PA (1993) Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvation. J Am Chem Soc 115(21):9620\u20139631. https:\/\/doi.org\/10.1021\/ja00074a030","journal-title":"J Am Chem Soc"},{"key":"846_CR83","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926\u2013935. https:\/\/doi.org\/10.1063\/1.445869","journal-title":"J Chem Phys"},{"issue":"14","key":"846_CR84","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1103\/PhysRevLett.45.1196","volume":"45","author":"M Parrinello","year":"1980","unstructured":"Parrinello M, Rahman A (1980) Crystal structure and pair potentials: a molecular-dynamics study. Phys Rev Lett 45(14):1196\u20131199. https:\/\/doi.org\/10.1103\/PhysRevLett.45.1196","journal-title":"Phys Rev Lett"},{"issue":"12","key":"846_CR85","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1998","unstructured":"Hess B, Bekker H, Berendsen JCB, Fraaije JGE (1998) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18(12):1463\u20131472. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:12%3c1463::AID-JCC4%3e3.0.CO;2-H","journal-title":"J Comput Chem"},{"issue":"12","key":"846_CR86","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N-log(N) method for Ewald sums in large systems. J Chem Phys 98(12):10089\u201310092. https:\/\/doi.org\/10.1063\/1.464397","journal-title":"J Chem Phys"},{"key":"846_CR87","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s10822-020-00355-5","volume":"34","author":"J Chen","year":"2020","unstructured":"Chen J, Wang W, Sun H, Pang L, Yin B (2020) Mutation-mediated influences on binding of anaplastic lymphoma kinase to Crizotinib decoded by multiple replica Gaussian accelerated molecular dynamics. J Comput-Aided Mol Des 34:1289\u20131305. https:\/\/doi.org\/10.1007\/s10822-020-00355-5","journal-title":"J Comput-Aided Mol Des"},{"issue":"8","key":"846_CR88","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1021\/acs.jcim.5c00096","volume":"65","author":"J Chen","year":"2025","unstructured":"Chen J, Wang J, Yang W, Zhao L, Su J (2025) Activity regulationand conformation response of JanusKinase 3 mediated by phosphorylation: Exploration from correlation network analysis and Markov Model. J Chem Inf Model 65(8):4189\u20134205. https:\/\/doi.org\/10.1021\/acs.jcim.5c00096","journal-title":"J Chem Inf Model"},{"key":"846_CR89","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-981-15-9235-5_4","volume-title":"Recent advances of the fragment molecular orbital method: enhanced performance and applicability","author":"Y Mochizuki","year":"2021","unstructured":"Mochizuki Y, Nakano T, Sakakura K, Okiyama Y, Watanabe H, Kato K, Akinaga Y, Sato S, Yamamoto J, Yamashita K, Murase T, Ishikawa T, Komeiji Y, Kato Y, Watanabe N, Tsukamoto T, Mori H, Okuwaki K, Tanaka S, Kato A, Watanabe C (2021) Fukuzawa K (2021) The ABINIT-MP program. In: Mochizuki Y, Tanaka S, Fukuzawa K (eds) Recent advances of the fragment molecular orbital method: enhanced performance and applicability. Springer, Singapore, pp 53\u201367"},{"key":"846_CR90","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00214-004-0602-3","volume":"112","author":"Y Mochizuki","year":"2004","unstructured":"Mochizuki Y, Nakano T, Koikegami S, Tanimori S, Abe Y, Nagashima U, Kitaura K (2004) A parallelized integral-direct second-order M\u00f8ller-Plesset perturbation theory method with a fragment molecular orbital scheme. Theor Chem Acc 112:442\u2013452. https:\/\/doi.org\/10.1007\/s00214-004-0602-3","journal-title":"Theor Chem Acc"},{"issue":"4\u20136","key":"846_CR91","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cplett.2004.08.082","volume":"396","author":"Y Mochizuki","year":"2004","unstructured":"Mochizuki Y, Koikegami S, Nakano T, Amari S, Kitaura K (2004) Large scale MP2 calculations with fragment molecular orbital scheme. Chem Phys Lett 396(4\u20136):473\u2013479. https:\/\/doi.org\/10.1016\/j.cplett.2004.08.082","journal-title":"Chem Phys Lett"},{"issue":"4-6","key":"846_CR92","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cplett.2008.03.090","volume":"457","author":"Y Mochizuki","year":"2008","unstructured":"Mochizuki Y, Yamashita K, Murase T, Nakano T, Fukuzawa K, Takematsu K, Watanabe H, Tanaka S (2008) Large scale FMO-MP2 calculations on a massively parallel-vector computer. Chem Phys Lett 457(4\u20136):396\u2013403. https:\/\/doi.org\/10.1016\/j.cplett.2008.03.090","journal-title":"Chem Phys Lett"},{"key":"846_CR93","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1039\/D0RA09555A","volume":"11","author":"K Akisawa","year":"2021","unstructured":"Akisawa K, Hatada R, Okuwaki K, Mochizuki Y, Fukuzawa K, Komeiji Y, Tanaka S (2021) Interaction analyses of SARS-CoV-2 spike protein based on fragment molecular orbital calculations. RSC Adv 11:3272\u20133279. https:\/\/doi.org\/10.1039\/D0RA09555A","journal-title":"RSC Adv"},{"issue":"4","key":"846_CR94","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/(SICI)1097-461X(2000)78:4<226::AID-QUA4>3.0.CO;2-N","volume":"78","author":"C Dykstra","year":"2000","unstructured":"Dykstra C, Davidson E (2000) Enhanced second-order treatment of electron pair correlation. Int J Quantum Chem 78(4):226\u2013236. https:\/\/doi.org\/10.1002\/(SICI)1097-461X(2000)78:4%3c226::AID-QUA4%3e3.0.CO;2-N","journal-title":"Int J Quantum Chem"},{"issue":"6","key":"846_CR95","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0009-2614(00)00070-1","volume":"318","author":"T Nakano","year":"2000","unstructured":"Nakano T, Kaminuma T, Sato T, Akiyama Y, Uebayasi M, Kitaura K (2000) Fragment molecular orbital method: application to polypeptides. Chem Phys Lett 318(6):614\u2013618. https:\/\/doi.org\/10.1016\/S0009-2614(00)00070-1","journal-title":"Chem Phys Lett"},{"issue":"7","key":"846_CR96","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1021\/acs.jcim.0c00283","volume":"60","author":"R Hatada","year":"2020","unstructured":"Hatada R, Okuwaki K, Mochizuki Y, Handa Y, Fukuzawa K, Komeiji Y, Okiyama Y, Tanaka S (2020) Fragment molecular orbital based interaction analyses on COVID-19 main protease\u2013inhibitor N3 complex (PDB ID: 6LU7). J Chem Inf Model 60(7):3593\u20133602. https:\/\/doi.org\/10.1021\/acs.jcim.0c00283","journal-title":"J Chem Inf Model"},{"issue":"1","key":"846_CR97","doi-asserted-by":"publisher","DOI":"10.1093\/chemle\/upaf238","volume":"55","author":"R Yoshine","year":"2026","unstructured":"Yoshine R, Doi H, Okuwaki K, Mochizuki Y (2026) Automatic detection of interacting carbonyl oxygens in peptide bond for the fragment molecular orbital method. Chem Lett 55(1):upaf238. https:\/\/doi.org\/10.1093\/chemle\/upaf238","journal-title":"Chem Lett"},{"key":"846_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.comptc.2024.114885","volume":"1241","author":"DG Fedorov","year":"2024","unstructured":"Fedorov DG (2024) Fragmentation of disulfide bonds in the fragment molecular orbital method. Comput Theor Chem 1241:114885. https:\/\/doi.org\/10.1016\/j.comptc.2024.114885","journal-title":"Comput Theor Chem"},{"issue":"2","key":"846_CR99","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1021\/acs.jcim.0c01062","volume":"61","author":"D Takaya","year":"2021","unstructured":"Takaya D, Watanabe C, Nagase S, Kamisaka K, Okiyama Y, Moriwaki H, Yuki H, Sato T, Kurita N, Yagi Y, Takagi T, Kawashita N, Takaba K, Ozawa T, Takimoto-Kamimura M, Tanaka S, Fukuzawa K, Honma T (2021) FMODB: the world\u2019s first database of quantum mechanical calculations for biomacromolecules based on the fragment molecular orbital method. J Chem Inf Model 61(2):777\u2013794. https:\/\/doi.org\/10.1021\/acs.jcim.0c01062","journal-title":"J Chem Inf Model"},{"key":"846_CR100","unstructured":"FMODB: fragment molecular orbital database.\u00a0https:\/\/fmodd.jp\/top-en\/"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00846-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00846-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00846-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:24:49Z","timestamp":1780025089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00846-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00846-x","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}